help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ten BRINKE, A.
Right arrow Articles by BEL, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ten BRINKE, A.
Right arrow Articles by BEL, E. H.

Am. J. Respir. Crit. Care Med., Volume 164, Number 5, September 2001, 744-748

Factors Associated with Persistent Airflow Limitation in Severe Asthma

ANNEKE ten BRINKE, AEILKO H. ZWINDERMAN, PETER J. STERK, KLAUS F. RABE, and ELISABETH H. BEL

Department of Pulmonary Diseases, Leiden University Medical Center, and Department of Medical Statistics, Leiden University, Leiden, The Netherlands

Persistent airflow limitation can develop in nonsmoking patients with asthma. However, the prevalence and risk factors for airways obstruction with incomplete reversibility in asthma are unknown. We assessed the prevalence of persistent airflow limitation (defined as postbronchodilator FEV1 or FEV1/VC < 75% predicted) in 132 nonsmoking outpatients with severe asthma visiting chest physicians in general hospitals in The Netherlands. They had used inhaled corticosteroids (>=  1,600 µg/d) and/or daily oral prednisone and long-acting bronchodilators for > 1 yr. In addition, we examined whether persistent airways obstruction in these patients was associated with specific clinical characteristics (age at onset, smoking history, atopic status, bronchodilator reversibility, provocative concentration of histamine causing a 20% decrease in FEV1 [PC20histamine]) or markers of inflammation (exhaled nitric oxide [NO], blood eosinophils, total IgE; and eosinophilia or neutrophilia in induced sputum). Multiple logistic regression analyses were used to calculate adjusted odds ratios (OR). Persistent airflow limitation was observed in 49% of the patients in the study, and apart from older age and longer asthma duration, was strongly associated with a sputum eosinophils percent >=  2% (OR = 7.7; confidence interval [CI]: 2.4 to 25), PC20histamine =< 1.0 mg/ml (OR = 3.9; CI: 1.2 to 13), and adult onset (>=  18 yr) of asthma (OR = 3.3; CI: 1.2 to 9). Only sputum eosinophilia appeared to be independently associated with persistent airflow limitation (OR = 8.9; CI: 1.3 to 59). In conclusion, persistent airflow limitation is common in adult patients with severe asthma, and is associated with adult onset of the disease, airway hyperresponsiveness, and most importantly, sputum eosinophilia. These findings suggest that eosinophilic airway inflammation contributes to persistent airflow limitation in severe asthma. Whether reduction of sputum eosinophils with more vigorous treatment leads to a better prognosis in severe asthma is still an open question.

Keywords: asthma; severity of illness index; airway obstruction; sputum; eosinophilia




This article has been cited by other articles:


Home page
 Eur Respir JHome page
C. J. Bossley, S. Saglani, C. Kavanagh, D. N. R. Payne, N. Wilson, L. Tsartsali, M. Rosenthal, I. M. Balfour-Lynn, A. G. Nicholson, and A. Bush
Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma
Eur. Respir. J., November 1, 2009; 34(5): 1052 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. W. Kim, H. M. Jee, Y. H. Park, B. S. Choi, M. H. Sohn, and K.-E. Kim
Relationship Between Amphiregulin and Airway Inflammation in Children With Asthma and Eosinophilic Bronchitis
Chest, September 1, 2009; 136(3): 805 - 810.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P G Gibson and J L Simpson
The overlap syndrome of asthma and COPD: what are its features and how important is it?
Thorax, August 1, 2009; 64(8): 728 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. E. Wenzel, P. J. Barnes, E. R. Bleecker, J. Bousquet, W. Busse, S.-E. Dahlen, S. T. Holgate, D. A. Meyers, K. F. Rabe, A. Antczak, et al.
A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-{alpha} Blockade in Severe Persistent Asthma
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 549 - 558.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. R. Taylor, E. D. Bateman, L-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, J. C. de Jongste, et al.
A new perspective on concepts of asthma severity and control
Eur. Respir. J., September 1, 2008; 32(3): 545 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. H. van Veen, A. ten Brinke, P. J. Sterk, J. K. Sont, S. A. Gauw, K. F. Rabe, and E. H. Bel
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Eur. Respir. J., August 1, 2008; 32(2): 344 - 349.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Lahzami and G. G. King
Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment
Eur. Respir. J., June 1, 2008; 31(6): 1145 - 1147.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. L. Sorkness, E. R. Bleecker, W. W. Busse, W. J. Calhoun, M. Castro, K. F. Chung, D. Curran-Everett, S. C. Erzurum, B. M. Gaston, E. Israel, et al.
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation
J Appl Physiol, February 1, 2008; 104(2): 394 - 403.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. H. Lee, T. Haselkorn, L. Borish, L. Rasouliyan, B. E. Chipps, and S. E. Wenzel
Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma: Insights From the TENOR Study
Chest, December 1, 2007; 132(6): 1882 - 1889.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. E. Shaw, M. A. Berry, B. Hargadon, S. McKenna, M. J. Shelley, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord
Association Between Neutrophilic Airway Inflammation and Airflow Limitation in Adults With Asthma
Chest, December 1, 2007; 132(6): 1871 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. R. Sears
Lung function decline in asthma
Eur. Respir. J., September 1, 2007; 30(3): 411 - 413.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
T. R. Bai, J. M. Vonk, D. S. Postma, and H. M. Boezen
Severe exacerbations predict excess lung function decline in asthma
Eur. Respir. J., September 1, 2007; 30(3): 452 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. L. James and S. Wenzel
Clinical relevance of airway remodelling in airway diseases
Eur. Respir. J., July 1, 2007; 30(1): 134 - 155.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
IlonkaH. van Veen, PieterS. Hiemstra, A. ten Brinke, A. Roos, RenateM. Verhoosel, JaapK. Sont, PeterJ. Sterk, KlausF. Rabe, and ElisabethH. Bel
Mannose binding lectin (MBL) levels predict lung function decline in severe asthma
Eur. Respir. Rev., December 1, 2006; 15(101): 224 - 225.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. T. Holgate, Y. Yang, H.-M. Haitchi, R. M. Powell, J. W. Holloway, H. Yoshisue, Y. Y. Pang, J. Cakebread, and D. E. Davies
The Genetics of Asthma: ADAM33 as an Example of a Susceptibility Gene.
Proceedings of the ATS, July 1, 2006; 3(5): 440 - 443.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. C. Erzurum
Inhibition of Tumor Necrosis Factor {alpha} for Refractory Asthma
N. Engl. J. Med., February 16, 2006; 354(7): 754 - 758.
[Full Text] [PDF]

Home page
 ThoraxHome page
P Lange, H Scharling, C S Ulrik, and J Vestbo
Inhaled corticosteroids and decline of lung function in community residents with asthma
Thorax, February 1, 2006; 61(2): 100 - 104.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P H Howarth, K S Babu, H S Arshad, L Lau, M Buckley, W McConnell, P Beckett, M Al Ali, A Chauhan, S J Wilson, et al.
Tumour necrosis factor (TNF{alpha}) as a novel therapeutic target in symptomatic corticosteroid dependent asthma
Thorax, December 1, 2005; 60(12): 1012 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. ten Brinke, P. J. Sterk, A. A. M. Masclee, P. Spinhoven, J. T. Schmidt, A. H. Zwinderman, K. F. Rabe, and E. H. Bel
Risk factors of frequent exacerbations in difficult-to-treat asthma
Eur. Respir. J., November 1, 2005; 26(5): 812 - 818.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. D. Levy, C. Bonnans, E. S. Silverman, L. J. Palmer, G. Marigowda, E. Israel, and for the Severe Asthma Research Program, National H
Diminished Lipoxin Biosynthesis in Severe Asthma
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 824 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. L. J. van Rensen, J. K. Sont, C. E. Evertse, L. N. A. Willems, T. Mauad, P. S. Hiemstra, P. J. Sterk, and the AMPUL Study Group
Bronchial CD8 Cell Infiltrate and Lung Function Decline in Asthma
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 837 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Wenzel
Severe Asthma in Adults
Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 149 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Berry, B. Hargadon, A. Morgan, M. Shelley, J. Richter, D. Shaw, R. H. Green, C. Brightling, A. J. Wardlaw, and I. D. Pavord
Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma
Eur. Respir. J., June 1, 2005; 25(6): 986 - 991.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. W.S. Ko, C. Diba, M. Roth, K. McKay, P. R.A. Johnson, C. Salome, and G. G. King
A Comparison of Airway and Serum Matrix Metalloproteinase-9 Activity Among Normal Subjects, Asthmatic Patients, and Patients With Asthmatic Mucus Hypersecretion
Chest, June 1, 2005; 127(6): 1919 - 1927.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. S. Tepper, R. Ramchandani, E. Argay, L. Zhang, Z. Xue, Y. Liu, and S. J. Gunst
Chronic strain alters the passive and contractile properties of rabbit airways
J Appl Physiol, May 1, 2005; 98(5): 1949 - 1954.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
C. J. Danek, C. M. Lombard, D. L. Dungworth, P. G. Cox, J. D. Miller, M. J. Biggs, T. M. Keast, B. E. Loomas, W. J. Wizeman, J. C. Hogg, et al.
Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs
J Appl Physiol, November 1, 2004; 97(5): 1946 - 1953.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. ten Brinke, A. H. Zwinderman, P. J. Sterk, K. F. Rabe, and E. H. Bel
"Refractory" Eosinophilic Airway Inflammation in Severe Asthma: Effect of Parenteral Corticosteroids
Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 601 - 605.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
G. L. Colice
Categorizing Asthma Severity: An Overview of National Guidelines
Clin. Med. Res., August 1, 2004; 2(3): 155 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. A. Covar, J. D. Spahn, J. R. Murphy, and S. J. Szefler
Progression of Asthma Measured by Lung Function in the Childhood Asthma Management Program
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 234 - 241.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. F. Donohue
Therapeutic Responses in Asthma and COPD: Bronchodilators
Chest, August 1, 2004; 126(2_suppl_1): 125S - 137S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Bumbacea, D. Campbell, L. Nguyen, D. Carr, P.J. Barnes, D. Robinson, and K.F. Chung
Parameters associated with persistent airflow obstruction in chronic severe asthma
Eur. Respir. J., July 1, 2004; 24(1): 122 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D.S. Robinson, D.A. Campbell, S.R. Durham, J. Pfeffer, P.J. Barnes, and K.F. Chung
Systematic assessment of difficult-to-treat asthma
Eur. Respir. J., September 1, 2003; 22(3): 478 - 483.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C.J.A. Duncan, A. Lawrie, M.G. Blaylock, J.G. Douglas, and G.M. Walsh
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Eur. Respir. J., September 1, 2003; 22(3): 484 - 490.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. C. Henderson, E. P. Ingenito, H. Atileh, E. Israel, B. Suki, and K. R. Lutchen
Selected Contribution: How does airway inflammation modulate asthmatic airway constriction? An antigen challenge study
J Appl Physiol, August 1, 2003; 95(2): 873 - 882.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
L G Heaney, E Conway, C Kelly, B T Johnston, C English, M Stevenson, and J Gamble
Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol
Thorax, July 1, 2003; 58(7): 561 - 566.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Benayoun, A. Druilhe, M.-C. Dombret, M. Aubier, and M. Pretolani
Airway Structural Alterations Selectively Associated with Severe Asthma
Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1360 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, M. Romagnoli, L. Corbetta, G. Casoni, K. Busljetic, G. Turato, G. Ligabue, A. Ciaccia, M. Saetta, and A. Papi
Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 418 - 424.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
Poster presentations
Thorax, December 1, 2002; 57(90003): iii48 - 94.
[Full Text] [PDF]

Home page
 ChestHome page
M. J. Alvarez Puebla, R. Castillo, A. Rey, N. Ortega, C. Blanco, and T. Carrillo
Sputum Eosinophilia and Maximal Airway Narrowing in Dermatophagoides pteronyssinus Allergic Rhinitis Patients: Only Rhinitis or Rhinitis Plus Mild Asthma?
Chest, November 1, 2002; 122(5): 1560 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  ATS 2008 State of the Art Course